Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

NxStage Medical Inc (NASDAQ:NXTM)

14.28
Delayed Data
As of Jul 31
 +0.29 / +2.07%
Today’s Change
11.50
Today|||52-Week Range
19.63
-20.36%
Year-to-Date
No recent news for NxStage Medical Inc.

Today’s Trading

Previous close13.99
Today’s open14.05
Day’s range14.05 - 14.59
Volume399,829
Average volume (3 months)540,993
Market cap$876.5M
Dividend yield--
Data as of 3:59pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)-25.81%
Earnings growth (this year)+8.65%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+14.45%
P/E ratioNM
Price/Sales3.67
Price/Book4.56

Competitors

 Today’s
change
Today’s
% change
LXRXLexicon Pharmaceutic...-0.05-0.59%
KERXKeryx Biopharmaceuti...+0.23+2.97%
AMRIAlbany Molecular Res...+0.06+0.28%
SGMOSangamo BioSciences ...+0.35+3.98%
Data as of 3:59pm ET, 07/31/2015

Financials

Next reporting dateAugust 6, 2015
EPS forecast (this quarter)-$0.10
Annual revenue (last year)$301.5M
Annual profit (last year)-$23.9M
Net profit margin-7.94%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chief Executive Officer &
Director
Jeffrey H. Burbank
President
Joseph E. Turk
Corporate headquarters
Lawrence, Massachusetts

Forecasts